Temporary regression of Merkel cell carcinoma metastases after cessation of cyclosporine [1]

Transplantation

Volumn 73, Issue 11, 2002, Pages 1849-1850

  Friedlaender, Michael M ^a   Rubinger, Dvora ^a   Rosenbaum, Eli ^a   Amir, Gail ^a   Siguencia, Edgar ^a  

^a HADASSAH HEBREW UNIVERSITY MEDICAL CENTER   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

AZATHIOPRINE; CARBOPLATIN; CYCLOSPORIN; DOXORUBICIN; ETOPOSIDE; METHYLPREDNISOLONE; PREDNISONE; VINCRISTINE;

ADULT; CANCER GROWTH; CANCER REGRESSION; CASE REPORT; COMPUTER ASSISTED TOMOGRAPHY; DOSE TIME EFFECT RELATION; DRUG WITHDRAWAL; GRAFT REJECTION; HISTOPATHOLOGY; HUMAN; IMMUNOHISTOCHEMISTRY; KIDNEY TRANSPLANTATION; LETTER; MALE; MERKEL CELL TUMOR; METASTASIS; PRIORITY JOURNAL; QUALITY OF LIFE; TERMINAL DISEASE;

EID: 0037096705     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/00007890-200206150-00028     Document Type: Letter

References (6)

1. Merkel's cell carcinoma in organ recipients. A report of 41 cases
2. Kaposi's sarcoma after renal transplantation: Withdrawal of immunosuppression or local irradiation?
3. Reversibility of lymphomas and lymphoproliferative lesions developing under cyclosporin-steroid therapy
4. The efficiency of adjuvant cytostatic therapy after organ transplantation for malignancy; an experimental study with a combined transplantation/tumor model
5. In vivo expression of transforming growth factor-beta1 in humans: Stimulation by cyclosporine
6. Cyclosporine induces cancer progression by a cell-autonomous mechanism